Inflammatory Bowel Disease Market Set For Strong Growth By 2034, Predicts Delveinsight
DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...
Bowel cancer breakthrough as game-changing test could detect who will develope disease
The groundbreaking study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in ...
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Algorithm study 90% accurate predicting bowel cancer
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Medical News Today6d
Wearable devices like Fitbit can predict IBD flares 7 weeks in advance
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Medscape2d
Women Researchers Remain Underrepresented in Pharma-Sponsored IBD Presentations
Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...
Rolling Out10h
Ulcerative colitis and its impact on daily life
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
Everyday Health9d
IBD Leads to Financial Sacrifices, Survey Shows — 5 Ways to Manage Costs Now
Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...
Researchers identify new genes predisposing to inflammation of the iris
An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis.
Ibj.com1d
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The American Journal of Managed Care6d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
New colorectal cancer prediction test is more than 90% accurate
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.